ViroDefense Inc Announces Selection of Poliovirus Antiviral Preclinical... (upport ViroDefense in its efforts to add...)

ViroDefense Inc Announces Selection of Poliovirus Antiviral Preclinical Candidate

Date:6/3/2008

upport ViroDefense in its efforts to address a clear public health need during both the final stages of the polio eradication effort and in the post-eradication era," said Thomas P. Koestler, Ph.D., President of Schering-Plough Research Institute.

Background

The Global Polio Eradication Initiative, launched by the World Health Organization (WHO) in 1988, is approaching its goal and expects to certify the world free of polio in the near future. Protecting the estimated $7 billion, two-decade investment will depend on the policies, defense strategies and emergency response capabilities available during these final stages of eradication and in the post-eradication era. These safeguards must protect against virus re-introduction, and in the event of re-introduction, must rapidly contain, control and eliminate the virus.

In November 2005, the National Research Council (NRC) held a workshop, at the request of the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC), to discuss the role and utility of a polio antiviral drug in the efforts to eradicate poliovirus and in the defense of a polio-free world post-eradication. It was concluded that a polio antiviral drug, used alone or in conjunction with current vaccines, would be useful in the control of polio outbreaks, providing increased response flexibility and improved effectiveness. It was further recommended that drug development begin immediately. Currently, there are no drugs for treatment or prevention of poliovirus disease.

In October 2006, the Task Force for Child Survival and Development proposed that a Poliovirus Antiviral Initiative be established to implement the NRC recommendations. The Advisory Committee on Poliomyelitis Eradication (ACPE) supported the proposal and recommended action. In June 2007, the CDC acted on the ACPE recommendations by contracting the Task Force to facilitate development of effective polio antiviral drugs for global public hea
'/>"/>

SOURCE ViroDefense Inc
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3
Related medicine technology :

1. BioElectronics Announces Profitability Breakeven and Additional Clinical Trials
2. Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
3. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
4. Trubion Announces Presentation of Positive TRU-016 Data at ASCO
5. Alliance Pharmaceutical Corp. Announces Approval of Proposed Actions at Annual Shareholders Meeting
6. Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
7. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting
8. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
9. IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients
10. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
11. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma

Post Your Comments:

(Date:12/16/2009)... -- Accuray Incorporated (Nasdaq: ARAY ), a global ... its president and chief executive officer, Euan S. Thomson, ... J.P. Morgan Healthcare Conference in San Francisco on Wednesday, ... ,, A live webcast of each presentation will ... the Company,s Web site at http://www.accuray.com . ...

(Date:12/16/2009)... DATATRAK International, Inc. (OTCQX: DATA), ... global eClinical solutions for the clinical trials ... version 9.0 eClinical Software. This release ... and service delivery and introduces two new ... the DATATRAK Learning Center(TM) and the DATATRAK ...

(Date:12/16/2009)... -- HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA) an online ... million in 12% per annum short term debt financing. ... initial drawdown of $500,000, with accrued interest and principal ... with accrued interest and principal repayable in one year ... cashflow positive for any calendar month prior to December ...

[0] Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference [0] DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM)[0] HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing

... Program to Advance to the Clinic Within a Year; Studies ... Generate Milestone Payment to ... Inc. (Nasdaq: MITI ) and Nycomed today announced the ... MT203.,Micromet received $775,000 (500,000 euros) from Nycomed for the achievement,of ...

... Companies confirm the start of TRILOGY ACS clinical trial ... medically managed ACS patients, TOKYO and INDIANAPOLIS, June ... and Company (NYSE: LLY ),said that the U.S. ... for the prasugrel new drug application (NDA) based on,supplemental ...

Other Medicine Technology:Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases 2 Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases 3 Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases 4 FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel 2 FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel 3 FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel 4

Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel

(Date:12/17/2009)... Dec. 17 The recently opened ... out in the community in full force this holiday ... on December 13th, benefiting the Arthritis Foundation, a non-profit ... arthritis. The event boasted 1,500 attendees, spotlighting LSI,s passion ... is a renowned, national fundraiser and a festive way ...

(Date:12/17/2009)... University of Jerusalem Kuvin Center for the Study ... $5 million grant from the Bill & Melinda ... Ethiopia. , The project will be led by ... the Institute of Medical Research Israel-Canada at the ... entitled ,Studies on the ecology and transmission dynamics ...

(Date:12/17/2009)... How Exercise Has Helped, Healed, and Preserved Good Health ... ... Racquet & Sportsclub Association (IHRSA) announced today that as part of ... all ages and abilities to make 2010 the year we unite ... America wherein regular daily exercise is highly valued and widely practiced. ...

(Date:12/17/2009)... to perform fill/finish of nimotuzumab , ... ... and CEO of Therapure Biopharma Inc. and David Allan, Chairman ... of an agreement under which Therapure Biopharma will provide aseptic ... licensed to YM’s majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by ...

(Date:12/17/2009)... Abaxis, Inc. (Nasdaq: ABAX ), ... instruments and rapid tests for the medical, research ... entered the production animal diagnostics marketplace with its ... This is a USDA-licensed test for Avian Influenza ... ducks. The disposable, non-instrumented device, providing results in ...

Breaking Medicine News(10 mins):Health News:Laser Spine Institute (LSI) Supports Jingle Bell Run 2 Health News:Hebrew U. receives $5 million for research on leishmaniasis in Ethiopia 2 Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 2 Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 3 Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 4 Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 5 Health News:Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership 2 Health News:Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership 3 Health News:Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership 4 Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 2 Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 3 Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 4

[0] Laser Spine Institute (LSI) Supports Jingle Bell Run [0] Hebrew U. receives $5 million for research on leishmaniasis in Ethiopia [0] IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active [0] Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership [0] ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit

... Mich., Oct. 3 WHNN radio personality,Bob Hughes, a well-known ... Mobile Care Hearing which is moving to Saginaw this,month. ... Rock ,n,Roll music and the quality of my life has ... devices at Mobile Care Hearing,",says Hughes. "I am really enjoying ...

... 3 Pink tags will be on display,throughout Food ... as the,supermarket chain partners with vendors and suppliers to ... the month, pink tags can be found on shelves ... Nevada and Foods Co stores in,Central and Northern California ...

... 3 President Bush,s veto today,of a bill ... of,children from families with low incomes creates a ... says Oral Health America, a national,advocacy organization. President ... children eligible for coverage through a,bipartisan, bicameral agreement ...

... AIRES, Argentina, October 3, 2007 The first reported ... more than two-thirds of patients with moderate to severe ... achieved at least a 75 percent reduction in psoriasis ... as measured by the Psoriasis Area and Severity Index ...

... The Stop & Shop Supermarket,Company, Giant Food and General ... for the Cure with the Pink for the Cure Program. ... Shop/Giant,Consumer Advisor Andrea Astrachan, "and by purchasing ,Pink for the ... the fight against,breast cancer and help us donate to this ...

... Nurses,Association/National Nurses Organizing Committee today condemned President,Bush,s veto of ... "Listening to the overheated rhetoric coming out of ... gone but his legacy lives on," said Zenei,Cortez, RN, ... for his recent claims that legislators who passed the ...

Other Medicine News:Health News:WHNN's Bob Hughes Fitted With Hearing Aids by Mobile Care Hearing Clinic Now Serving Saginaw Area 2 Health News:Food 4 Less/Foods Co 'Pink Tag' Campaign to Raise $150,000 for Breast Cancer Awareness in October 2 Health News:SCHIP Veto a Big Cavity for Children's Oral Healthcare, Advocates Say 2 Health News:Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis 2 Health News:Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis 3 Health News:Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis 4 Health News:Stop & Shop and Giant Food Join General Mills in Pink for the Cure 2 Health News:California Nurses Association Blasts Bush for Veto on Children's Health 2

WHNN's Bob Hughes Fitted With Hearing Aids by Mobile Care Hearing Clinic Now Serving Saginaw Area Food 4 Less/Foods Co 'Pink Tag' Campaign to Raise $150,000 for Breast Cancer Awareness in October SCHIP Veto a Big Cavity for Children's Oral Healthcare, Advocates Say Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis Stop & Shop and Giant Food Join General Mills in Pink for the Cure California Nurses Association Blasts Bush for Veto on Children's Health

... MJS anatomic knee system ... durability, minimize polyethylene wear ... to minimize contact stress ... to achieve a well ...

The Balanced Knee™ system provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results....

... a cruciate sparing version which provides ... both resurfacing and inset patellas. Precision ... and fit with tibial articular surface ... cutting guide peg locations provide easy ...

... a femoral option and tibial insert which provides ... 60 degrees of flexion to induce a smooth ... degrees of flexion. Femoral component comes in a ... The constrained tibial insert in conjunction with the ...

Medicine Products:

MJS™ Anatomic Knee System Balanced Knee™ System Optetrak Cruciate Retaining Foundation® Posterior Stabilized Knee

ViroDefense Inc Announces Selection of Poliovirus Antiviral Preclinical...(upport ViroDefense in its efforts to add...),Health